//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~isPartOf:"The European journal of health economics : HEPAC ; health economics in prevention and care"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: person:"Vooren, Katelijne"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Arzneimittel
3
Pharmaceuticals
3
Arzneimittelmarkt
1
Droge
1
Drogenkonsum
1
Drug
1
Drug consumption
1
EU countries
1
EU-Staaten
1
Generic drugs
1
Generika
1
Gesundheitskosten
1
Gesundheitspolitik
1
Gesundheitswesen
1
Health care costs
1
Health care system
1
Health policy
1
Italien
1
Italy
1
Pharmaceutical industry
1
Pharmaceutical market
1
Pharmaindustrie
1
Western Europe
1
Westeuropa
1
more ...
less ...
Online availability
All
Undetermined
2
Type of publication
All
Article
7
Type of publication (narrower categories)
All
Article in journal
6
Aufsatz in Zeitschrift
6
Language
All
English
6
Undetermined
1
Author
All
Garattini, Livio
7
Van de Vooren, Katelijne
6
Curto, Alessandro
4
Vooren, Katelijne
1
Published in...
All
The European journal of health economics : HEPAC ; health economics in prevention and care
Health Policy
4
PharmacoEconomics
4
The European Journal of Health Economics
3
Applied Health Economics and Health Policy
2
Source
All
ECONIS (ZBW)
6
OLC EcoSci
1
Showing
1
-
7
of
7
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Editorial: market approval for drugs in the EU : time to change direction?
Curto, Alessandro
;
Van de Vooren, Katelijne
;
Garattini, …
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
8
,
pp. 933-936
Persistent link: https://www.econbiz.de/10011869154
Saved in:
2
Italian risk-sharing agreements on drugs : are they worthwhile?
Garattini, Livio
;
Curto, Alessandro
;
Van de Vooren, …
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
1
,
pp. 1-3
Persistent link: https://www.econbiz.de/10011300361
Saved in:
3
Western European Markets for biosimilar and generic drugs : worth differentiating : Editorial
Garattini, Livio
;
Curto, Alessandro
;
Van de Vooren, …
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
7
,
pp. 683-687
Persistent link: https://www.econbiz.de/10011482938
Saved in:
4
Pricing of forthcoming therapies for hepatitis C in Europe : beyond cost-effectiveness?
Van de Vooren, Katelijne
;
Curto, Alessandro
;
Garattini, …
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
4
,
pp. 341-345
Persistent link: https://www.econbiz.de/10011299737
Saved in:
5
Could co-payments on drugs help to make EU health care systems less open to political influence?
Garattini, Livio
;
Van de Vooren, Katelijne
- In:
The European journal of health economics : HEPAC ; …
14
(
2013
)
5
,
pp. 709-713
Persistent link: https://www.econbiz.de/10010195586
Saved in:
6
Budget impact analysis in economic evaluation : a proposal for a clearer definition
Garattini, Livio
;
Van de Vooren, Katelijne
- In:
The European journal of health economics : HEPAC ; …
12
(
2011
)
6
,
pp. 499-502
Persistent link: https://www.econbiz.de/10009376102
Saved in:
7
Could co-payments on drugs help to make EU health care systems less open to political influence?
Garattini, Livio
;
Vooren, Katelijne
- In:
The European journal of health economics : HEPAC ; …
14
(
2013
)
5
,
pp. 709-713
Persistent link: https://www.econbiz.de/10010169392
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->